
The S&P/ASX 200 Index (ASX: XJO) is having a strong start to the week. In afternoon trade, the benchmark index is up 0.8% to 7,786.8 points.
Four ASX shares that are rising more than most today are listed below. Here’s why they are racing higher:
Cettire Ltd (ASX: CTT)
The Cettire share price is up 10% to $2.62. Investors have been buying this online luxury products retailer’s shares after it refuted allegations that it has fake products on its platform. The company commented: “Since commercial launch in 2017, Cettire has handled more than 2 million individual orders. There is not a single confirmed case of a non-genuine item being sold on Cettire’s platform.” Management also highlights that the negative media press has “sought to amplify the claims of parties who have openly taken short positions in Cettire shares and sought to profit from a short-term decline in the share price.”
Lendlease Group (ASX: LLC)
The Lendlease share price is up 10% to $6.47. This follows the release of a major strategy update this morning. The property developer revealed that it is aiming to simplify its global business and bring costs under control. This will see Lendlease exit its struggling international construction projects and focus on its integrated Australian real estate business with international investment management capabilities. These actions are expected to release $4.5 billion of capital from its offshore development projects and assets.
Neuren Pharmaceuticals Ltd (ASX: NEU)
The Neuren Pharmaceuticals share price is up 11% to $22.99. This has been driven by the release of a trial update. The top-line results from Neuren’s phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS) delivered a “statistically significant improvement” across all four efficacy measures. Neuren CEO Jon Pilcher commented: “We are very excited about the results of this first clinical trial in Pitt Hopkins patients. This underserved community has such urgent unmet need and we can now continue towards our goal of developing a first approved treatment.”
Sayona Mining Ltd (ASX: SYA)
The Sayona Mining share price is up 7% to 4.5 cents. This morning, this lithium miner released the results from 94 new drillholes at its Moblan Lithium Project in Canada. Management highlights that the drilling result demonstrate the high grade nature of the highly strategic asset. Sayona’s Interim CEO, James Brown, commented: “We are delighted with the thick, high-grade drilling results at Moblan confirming it is one of the premier hard rock lithium deposits in North America. Most excitingly, it is clear there remains considerable potential for further expansion of the deposit which is open in all directions.”
The post Why Cettire, Lendlease, Neuren, and Sayona Mining shares are racing higher today appeared first on The Motley Fool Australia.
Should you invest $1,000 in Cettire Limited right now?
Before you buy Cettire Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cettire Limited wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
See The 5 Stocks
*Returns as of 5 May 2024
More reading
- Shorted ASX All Ords share rallies 8% despite ’empty box’ allegations
- Guess which ASX 200 healthcare share just rocketed 11% on ‘groundbreaking trial’
- Lendlease share price leaps 9% on plans to bring $4.5 billion back home
- Here is the latest lithium price forecast through to 2027
- 5 things to watch on the ASX 200 on Monday
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cettire. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply